Particle.news
Pricing Strategies Market Dynamics Market Control Drug Pricing Regulatory Implications Role as Middlemen Market Concentration Corporate Control Regulation Regulatory Practices Rebates Regulatory Actions Corporate Practices Corporate Ownership Stock Market Insurance Companies Market Regulation Market Influence Market Practices Market Consolidation
Lawmakers scrutinize PBMs' role in rising drug prices, as bipartisan reform efforts face challenges from lobbying and legislative gridlock.
